Zoetis Inc. (ZTS) は上場企業です ヘルスケア セクターの Drug Manufacturers - Specialty & Generic 業界で事業展開. 本社所在地は Parsippany, NJ, アメリカ. 現CEOは Kristin C. Peck.
ZTS を有する IPO日 2013-02-01, 13,800 名の正社員, に上場 NYSE, 時価総額 $51.12B.
Zoetis Inc. is a global animal health company that discovers, develops, manufactures, and commercializes medicines, vaccines, and diagnostic products for livestock and companion animals. The company serves cattle, swine, poultry, fish, sheep, dogs, cats, and horses through a comprehensive portfolio including vaccines, anti-infectives, parasiticides, pain management products, dermatology treatments, and medicated feed additives. Additionally, Zoetis provides diagnostic solutions such as point-of-care blood and urine analysis, rapid immunoassay tests, and reference laboratory services, along with nutritional and precision animal health products. The company distributes its products through veterinarians, livestock producers, retail outlets, and third-party veterinary distributors. Founded in 1952 and headquartered in Parsippany, New Jersey, Zoetis operates internationally to serve the global animal health market.
